. Author manuscript; available in PMC: 2013 Feb 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2011 Jun 15;18(2):220–228. doi: 10.1016/j.bbmt.2011.06.003

Table 6.

Comparison of costs for 3 months post autologous transplantation. (A) All ASCTs during the study period. (B) ASCTs with cryopreserved PBSC products containing a cumulative TNC dose of > 1.63 × 10⁹/kg.

(A)
	Pre-policy change		Post-policy change		P-value
	N	Median cost^* (range)	N	Median cost^* (range)	P-value
Inpatient	94	68.8 (8.7–223.7)	170	65.4 (22.3–267.7)	0.76
Outpatient	119	58.8 (21.0–330.8)	207	58.5 (0.3–294.0)	0.57

(B)
	Pre-policy change		Post-policy change		P-value
	N	Median cost^* (range)	N	Median cost^* (range)	P-value
Inpatient	32	65.1 (8.7–223.7)	47	69.2 (31.7–159.6)	0.67
Outpatient	29	59.3 (30.3–147.4)	46	68.3 (2.1–214.5)	0.25

Cost in $1000’s